Treatment of SARS with human interferons

Lancet

Volumn 362, Issue 9380, 2003, Pages 293-294

  Cinatl, J ^a   Morgenstern, B ^a   Bauer, G ^a   Chandra, P ^a   Rabenau, H ^a   Doerr, H W ^a  

^a GOETHE UNIVERSITY MEDICAL SCHOOL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; ANTIVIRUS AGENT; BETA INTERFERON; GAMMA INTERFERON; RECOMBINANT INTERFERON;

ANIMAL CELL; ARTICLE; CELL STRAIN CACO 2; CONTROLLED STUDY; CORONAVIRUS; DRUG EFFICACY; DRUG POTENCY; DRUG SELECTIVITY; DRUG SENSITIVITY; HONG KONG; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; SARS CORONAVIRUS; SEVERE ACUTE RESPIRATORY SYNDROME; UNITED STATES; VERO CELL; VIRUS ISOLATION; VIRUS PNEUMONIA; VIRUS REPLICATION;

EID: 0043200981     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(03)13973-6     Document Type: Article

References (5)

1. Drosten C., Gunther S., Preiser W., et al. Identification of a novel coronavirus in patients with severe acute respiratory syndrome. N Engl J Med. 348:2003;1967-1976.
2. Cinatl J., Morgenstern B., Bauer G., Chandra P., Rabenau H., Doerr H.W. Glycyrrhizin, an active component of liquorice roots, and replication of SARS-associated coronavirus. Lancet. 361:2003;2045-2046.
3. Garcia S., Crance J.M., Billecocq A., et al. Quantitative real-time PCR detection of Rift Valley fever virus and its application to evaluation of antiviral compounds. J Clin Microbiol. 39:2001;4456-4461.
4. Der S.D., Zhou A., Williams B.R., Silverman R.H. Identification of genes differentially regulated by interferon alpha, beta, or gamma using oligonucleotide arrays. Proc Natl Acad Sci USA. 95:1998;15623-15628.
5. Pitkaranta A., Nokso-Koivisto J., Jantti V., Takala A., Kilpi T., Hovi T. Lowered yields of virus-induced interferon production in leukocyte cultures and risk of recurrent respiratory infections in children. J Clin Virol. 14:1999;199-205.